Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/23/2022 | 809.09% | Roth Capital | → $5 | Initiates Coverage On | → Buy |
11/15/2021 | — | Noble Capital Markets | Downgrades | Outperform → Market Perform | |
03/24/2021 | 3536.36% | Noble Capital Markets | → $20 | Initiates Coverage On | → Outperform |
04/16/2019 | — | BTIG | Downgrades | Buy → Neutral | |
04/11/2019 | — | Oppenheimer | Downgrades | Outperform → Perform | |
03/06/2019 | — | Oppenheimer | Initiates Coverage On | → Outperform | |
11/20/2018 | 2445.45% | BTIG | → $14 | Upgrades | Neutral → Buy |
06/19/2018 | — | BTIG | Downgrades | Buy → Neutral | |
05/17/2018 | 2445.45% | BTIG | → $14 | Initiates Coverage On | → Buy |
Helius Medical Tech Questions & Answers
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Roth Capital on August 23, 2022. The analyst firm set a price target for $5.00 expecting HSDT to rise to within 12 months (a possible 809.09% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Helius Medical Tech (NASDAQ: HSDT) was provided by Roth Capital, and Helius Medical Tech initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Helius Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Helius Medical Tech was filed on August 23, 2022 so you should expect the next rating to be made available sometime around August 23, 2023.
While ratings are subjective and will change, the latest Helius Medical Tech (HSDT) rating was a initiated with a price target of $0.00 to $5.00. The current price Helius Medical Tech (HSDT) is trading at is $0.55, which is within the analyst's predicted range.